ANSTO is the new production partner of OncoBeta® GmbH in Australia
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Showing 1 - 13 of 13 results
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Theinstrument is typically used to study diffusing water molecules or yet larger molecules like polymers or biological molecules. In addition, Emu can reveal quantum-mechanical tunnelling.
Highlights of the Magnetism Project.
Archive of ANSTO research publications, seminars and short talks.
The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.
The Medium Energy- X-ray Absorption Spectroscopy beamlines provides access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.
Publications and resources from the Powder Diffraction beamline.
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.